Cargando…
Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
INTRODUCTION: Immunophenotyping, which is the identification of immune cell subsets based on antigen expression, is an integral technique used to determine changes of cell composition and activation in various disease states or as a response to different stimuli. As nanoparticles are increasingly ut...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353541/ https://www.ncbi.nlm.nih.gov/pubmed/37470031 http://dx.doi.org/10.3389/falgy.2023.1126012 |
_version_ | 1785074731569905664 |
---|---|
author | Newton, Hannah S. Zhang, Jenny Donohue, Duncan Unnithan, Ragi Cedrone, Edward Xu, Jie Vermilya, Alison Malys, Tyler Clogston, Jeffrey D. Dobrovolskaia, Marina A. |
author_facet | Newton, Hannah S. Zhang, Jenny Donohue, Duncan Unnithan, Ragi Cedrone, Edward Xu, Jie Vermilya, Alison Malys, Tyler Clogston, Jeffrey D. Dobrovolskaia, Marina A. |
author_sort | Newton, Hannah S. |
collection | PubMed |
description | INTRODUCTION: Immunophenotyping, which is the identification of immune cell subsets based on antigen expression, is an integral technique used to determine changes of cell composition and activation in various disease states or as a response to different stimuli. As nanoparticles are increasingly utilized for diagnostic and therapeutic applications, it is important to develop methodology that allows for the evaluation of their immunological impact. Therefore, the development of techniques such as immunophenotyping are desirable. Currently, the most common technique used to perform immunophenotyping is multicolor flow cytometry. METHODS: We developed two distinct multicolor flow cytometry immunophenotyping panels which allow for the evaluation of the effects of nanoparticles on the composition and activation status of treated human peripheral blood mononuclear cells. These two panels assess the presence of various lymphoid and myeloid-derived cell populations as well as aspects of their activation statuses—including proliferation, adhesion, co-stimulation/presentation, and early activation—after treatment with controls or nanoparticles. To conduct assay performance qualification and determine the applicability of this method to preclinical characterization of nanoparticles, we used clinical-grade nanoformulations (AmBisome, Doxil and Feraheme) and research-grade PAMAM dendrimers of different sizes (G3, G4 and G5) and surface functionalities (amine-, carboxy- and hydroxy-). RESULTS AND DISCUSSION: We found that formulations possessing intrinsic fluorescent properties (e.g., Doxil and AmBisome) interfere with accurate immunophenotyping; such interference may be partially overcome by dilution. In the absence of interference (e.g., in the case of dendrimers), nanoparticle size and surface functionalities determine their effects on the cells with large amine-terminated dendrimers being the most reactive. |
format | Online Article Text |
id | pubmed-10353541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103535412023-07-19 Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles Newton, Hannah S. Zhang, Jenny Donohue, Duncan Unnithan, Ragi Cedrone, Edward Xu, Jie Vermilya, Alison Malys, Tyler Clogston, Jeffrey D. Dobrovolskaia, Marina A. Front Allergy Allergy INTRODUCTION: Immunophenotyping, which is the identification of immune cell subsets based on antigen expression, is an integral technique used to determine changes of cell composition and activation in various disease states or as a response to different stimuli. As nanoparticles are increasingly utilized for diagnostic and therapeutic applications, it is important to develop methodology that allows for the evaluation of their immunological impact. Therefore, the development of techniques such as immunophenotyping are desirable. Currently, the most common technique used to perform immunophenotyping is multicolor flow cytometry. METHODS: We developed two distinct multicolor flow cytometry immunophenotyping panels which allow for the evaluation of the effects of nanoparticles on the composition and activation status of treated human peripheral blood mononuclear cells. These two panels assess the presence of various lymphoid and myeloid-derived cell populations as well as aspects of their activation statuses—including proliferation, adhesion, co-stimulation/presentation, and early activation—after treatment with controls or nanoparticles. To conduct assay performance qualification and determine the applicability of this method to preclinical characterization of nanoparticles, we used clinical-grade nanoformulations (AmBisome, Doxil and Feraheme) and research-grade PAMAM dendrimers of different sizes (G3, G4 and G5) and surface functionalities (amine-, carboxy- and hydroxy-). RESULTS AND DISCUSSION: We found that formulations possessing intrinsic fluorescent properties (e.g., Doxil and AmBisome) interfere with accurate immunophenotyping; such interference may be partially overcome by dilution. In the absence of interference (e.g., in the case of dendrimers), nanoparticle size and surface functionalities determine their effects on the cells with large amine-terminated dendrimers being the most reactive. Frontiers Media S.A. 2023-07-04 /pmc/articles/PMC10353541/ /pubmed/37470031 http://dx.doi.org/10.3389/falgy.2023.1126012 Text en © 2023 Newton, Zhang, Donohue, Unnithan, Cedrone, Xu, Vermilya, Malys, Clogston and Dobrovolskaia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Allergy Newton, Hannah S. Zhang, Jenny Donohue, Duncan Unnithan, Ragi Cedrone, Edward Xu, Jie Vermilya, Alison Malys, Tyler Clogston, Jeffrey D. Dobrovolskaia, Marina A. Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles |
title | Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles |
title_full | Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles |
title_fullStr | Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles |
title_full_unstemmed | Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles |
title_short | Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles |
title_sort | multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles |
topic | Allergy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353541/ https://www.ncbi.nlm.nih.gov/pubmed/37470031 http://dx.doi.org/10.3389/falgy.2023.1126012 |
work_keys_str_mv | AT newtonhannahs multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles AT zhangjenny multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles AT donohueduncan multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles AT unnithanragi multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles AT cedroneedward multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles AT xujie multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles AT vermilyaalison multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles AT malystyler multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles AT clogstonjeffreyd multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles AT dobrovolskaiamarinaa multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles |